-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
Wl2lrJXN9kyMMntnv5xPhwJ05G1/d70sEyodQdzJXRnsXzhbPZNUpHwX9mm1UVUk
E0lPERX8yELdfr21J9Qf+A==
SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13D Under the Securities Exchange Act of 1934 Royce Focus Trust, Inc. Common Stock 78080N108 Charles M. Royce, 745 Fifth Avenue, New York, New York 10151, (212) 508-4500 January 26, 2011 If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ]. Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. *
Washington, D.C. 20549
(Amendment No. 7)*
(Name of Issuer)
(Title of Class of Securities)
(CUSIP Number)
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
(Date of Event which Requires Filing
of this Statement)
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
(Continued on following page(s))
Page 1 of 5 Pages
CUSIP No. 78080N108 |
13D |
Page 2 of 5 Pages |
1 |
NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Charles M. Royce |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] |
3 |
SEC USE ONLY
|
4 |
SOURCE OF FUNDS* PF |
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] |
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. |
NUMBER OF SHARES BENEFICIALLY |
7 |
SOLE VOTING POWER 1,497,112 |
OWNED BY EACH REPORTING |
8 |
SHARED VOTING POWER
|
PERSON WITH |
9 |
SOLE DISPOSITIVE POWER 1,497,112 |
10 |
SHARED DISPOSITIVE POWER |
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,497,112 |
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] |
CUSIP No. 78080N108 |
13D |
Page 3 of 5 Pages |
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 7.58% |
14 |
TYPE OF REPORTING PERSON* IN |
*
SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 78080N108 |
13D |
Page 4 of 5 Pages |
Item 1. Security and Issuer. |
The title and class of equity securities to which this statement relates is Common Stock. |
The name and address of the principal executive offices of the Issuer are: |
Royce Focus Trust, Inc. |
745 Fifth Avenue |
New York, New York 10151 |
Item 2. Identity and Background. |
(a) The name of the person filing this statement is Charles M. Royce. |
(b) Mr. Royce's business address is 745 Fifth Avenue, New York, New York 10151. |
(c) Mr. Royce is President, Co-Chief Investment Officer and a member of the Board of Managers of Royce & Associates, LLC, a registered investment adviser whose clients include the Issuer and other registered investment companies. He is director/trustee and President of the Issuer and such other investment companies. These companies are located at 745 Fifth Avenue, New York, New York 10151. |
(d) Not applicable. |
(e) Not applicable. |
(f) Mr. Royce is a citizen of the United States. |
Item 3. Source and Amount of Funds or Other Consideration. |
Not applicable. |
Item 4. Purpose of Transaction. |
This schedule is being filed as a result of the sale of 151,908 shares of the Issuer's Common Stock over which Charles M. Royce had sole investment and voting discretion, in January - February 2011, for an aggregate value of $1,164,472, which decreased Mr. Royce's beneficial holdings of the Issuer's Common Stock in excess of one additional percentage point. |
CUSIP No. 78080N108 |
13D |
Page 5 of 5 Pages |
Item 5. Interest in Securities of Issuer. |
(a) Mr. Royce had sole investment and voting discretion over 1,497,112 shares or 7.58% of the Issuer's outstanding Common Stock as of February 4, 2011. This amount included 42,640 shares held by a charitable foundation in which Mr. Royce has no pecuniary interest. |
(b) Mr. Royce has sole voting and sole dispositive powers as to all of the shares shown in item 5(a) above. |
(c) In the 60 days prior to the date of filing of this statement, Mr. Royce effected the following sales of the Common Stock of the Issuer, which were effected in the open market and not previously reported on any Schedule 13D filing: (i) 59,000 shares @$7.61 on January 26, 2011, (ii) 20,000 shares @ $7.67 on January 27, 2011, (iii) 20,000 shares @ $7.62 on January 31, 2011, (iv) 30,000 shares @ $7.70 on February 1, 2011, (v) 10,000 shares @ $7.80 on February 2, 2011 and (vi) 12,908 shares @ $7.80 on February 3, 2011. |
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer. |
Not applicable. |
Item 7. Materials to be Filed as Exhibits. |
Not applicable. |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
February 4, 2011 |
|
(Date) |
|
/s/ Dani Eng, |
|
(Signature) |
|
Dani Eng, Attorney-in-Fact |
|